Medical Research News

RSS

UH researcher working to identify potential new therapeutic targets for kidney disease

Among the primary forms of kidney disease, focal segmental glomerulosclerosis (FSGS) is the most common and is marked by high circulating levels of the suPAR protein (soluble urokinase-type plasminogen activator receptor).

13 Jan 2021

MIND and Mediterranean diets correlated with later onset of Parkinson's disease

A new study from UBC researchers suggests a strong correlation between following the MIND and Mediterranean diets and later onset of Parkinson's disease (PD).

13 Jan 2021

Study reveals cardiac protein as a new target for different types of heart disease

Like a failing fuel pump that causes a loss of engine power in a car, a diseased heart can take a serious toll on the body's performance. For some patients, tasks like walking up a flight of stairs or walking across a room eventually turn into exhausting endeavors.

13 Jan 2021

Density of marijuana outlets associated with greater use among young adults

As marijuana outlets open after the drug is legalized, the density of those recreational retailers is associated with more use and a greater intensity of use among young adults, according to a new RAND Corporation study.

13 Jan 2021

Researchers explore link between work addiction risk and health-related outcomes

Workaholism or work addiction risk is a growing public health concern that can lead to many negative mental and physical health outcomes such as depression, anxiety or sleep disorder.

13 Jan 2021

Scientists identify key enzyme as driver of autoimmune blistering diseases

The Granzyme B (GzmB) enzyme, which accumulates in certain tissues as we age, has been identified as a driver of itchy and sometimes life-threatening autoimmune conditions known as pemphigoid diseases (PDs), which cause blistering and skin erosion below the skin's surface.

13 Jan 2021

Influenza drug enisamium a potential COVID-19 treatment

Researchers in Europe and the United States have demonstrated the potential of the influenza drug enisamium as a treatment for infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

13 Jan 2021

Study identifies features of potent SARS-CoV-2 neutralizing antibodies

Researchers at Columbia University have provided important insights into features of viral binding and recognition within a class of potent neutralizing antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

13 Jan 2021

How has the UK-derived SARS-CoV-2 mutant strain spread internationally?

Researchers analyzed Facebook-based mobility data and found that travelers from UK may have spread the new SARS-CoV-2 strain that originated in the UK to at least 16 countries by the beginning of December 2020.

13 Jan 2021

COVID-19 survivors can show persistent symptoms six months after recovery, study finds

A team of researchers conduct a large study exploring the persistence of COVID-19 symptoms in recovered patients.

13 Jan 2021

Moderna to develop three new mRNA-based vaccines against HIV, influenza, and the Nipah virus

Morderna has announced plans to develop a range of new mRNA-based vaccines against other viruses, including the influenza virus, human immunodeficiency virus (HIV), and the Nipah virus.

13 Jan 2021

Researchers map genetic changes that may have facilitated SARS-CoV-2’s jump from bats to humans

Researchers from the University of Cambridge and the Pirbright Institute in the UK have identified key genetic changes in SARS-CoV-2 that may be responsible for the virus’s jump from bats to humans. The team also determined which animals contain cellular receptors that allow the virus to enter cells more effectively, zoning in on potential animals that acted as an intermediary host in facilitating SARS-CoV-2’s zoonosis.

13 Jan 2021

New N501 SARS-CoV-2 mutation may have been circulating in Italy since August 2020

A recent study shows that mutated SARS-CoV-2 strains with a substitution at position 501 might have circulated unnoticed even before the end of September 2020, when the rapid emergence of B.1.1.7 lineage (carrying the N501Y mutation) was initially reported.

13 Jan 2021

New findings could help better understand the mechanisms underlying severe malaria

The levels of small molecules called microRNAs (miRNAs) circulating in blood could help identify early on children with life-threatening forms of malaria, according to a study led by the Barcelona Institute for Global Health, an institution supported by "la Caixa" Foundation, in collaboration with the Manhiça Health Research Center (CISM) in Mozambique.

13 Jan 2021

Study shows faster uptake of chemicals in people with a genetically weakened skin barrier

The ability of our skin to protect us from chemicals is something we inherit. Some people are less well-protected which could imply an increased risk of being afflicted by skin disease or cancer.

13 Jan 2021

People who take walks in forests or greenspaces may have higher stress coping abilities

Work causes so much stress that it's become a global public health issue. Stress's impact on mental and physical health can also hurt productivity and result in economic loss. A new study now finds that working people who regularly take walks in forests or greenspaces may have higher stress-coping abilities.

13 Jan 2021

New UK-derived SARS-CoV-2 variant does not affect neutralizing antibodies efficiency, study says

A team of scientists conducted structural analysis of a newly emerged UK variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). They present evidence that suggests that while the new variant has increased infectivity it is not resistant to neutralizing antibodies.

13 Jan 2021

Study shows distancing and mandatory masks can prevent 87% of campus COVID-19 infections

The combined effectiveness of three COVID-prevention strategies on college campuses--mask-wearing, social distancing, and routine testing--are as effective in preventing coronavirus infections as the Pfizer and Moderna vaccines approved by the U.S. Food and Drug Administration (FDA), according to a new study co-authored by a Case Western Reserve University researcher.

13 Jan 2021

College campuses at risk of becoming COVID-19 superspreaders, study shows

College campuses are at risk of becoming COVID-19 superspreaders for their entire county, according to a new vast study which shows the striking danger of the first two weeks of school in particular.

13 Jan 2021

Recurring glioblastomas with very few mutations are far more vulnerable to immunotherapies

Glioblastoma brain tumors are especially perplexing. Inevitably lethal, the tumors occasionally respond to new immunotherapies after they've grown back, enabling up to 20% of patients to live well beyond predicted survival times.

13 Jan 2021

Medical Research News

UH researcher working to identify potential new therapeutic targets for kidney disease

MIND and Mediterranean diets correlated with later onset of Parkinson's disease

Study reveals cardiac protein as a new target for different types of heart disease

Density of marijuana outlets associated with greater use among young adults

Researchers explore link between work addiction risk and health-related outcomes

Scientists identify key enzyme as driver of autoimmune blistering diseases

Influenza drug enisamium a potential COVID-19 treatment

Study identifies features of potent SARS-CoV-2 neutralizing antibodies

How has the UK-derived SARS-CoV-2 mutant strain spread internationally?

COVID-19 survivors can show persistent symptoms six months after recovery, study finds

Moderna to develop three new mRNA-based vaccines against HIV, influenza, and the Nipah virus

Researchers map genetic changes that may have facilitated SARS-CoV-2’s jump from bats to humans

New N501 SARS-CoV-2 mutation may have been circulating in Italy since August 2020

New findings could help better understand the mechanisms underlying severe malaria

Study shows faster uptake of chemicals in people with a genetically weakened skin barrier

People who take walks in forests or greenspaces may have higher stress coping abilities

New UK-derived SARS-CoV-2 variant does not affect neutralizing antibodies efficiency, study says

Study shows distancing and mandatory masks can prevent 87% of campus COVID-19 infections

College campuses at risk of becoming COVID-19 superspreaders, study shows

Recurring glioblastomas with very few mutations are far more vulnerable to immunotherapies

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News